National randomized controlled trial of virtual house calls for Parkinson disease

Conclusions:
Providing remote neurologic care directly into the homes of people with PD was feasible and was neither more nor less efficacious than usual in-person care. Virtual house calls generated great interest and provided substantial convenience.

ClinicalTrials.gov identifier:
NCT02038959.

Classification of evidence:
This study provides Class III evidence that for patients with PD, virtual house calls from a neurologist are feasible and do not significantly change quality of life compared to in-person visits. The study is rated Class III because it was not possible to mask patients to visit type.

Source: Neurology - September 11, 2017 Category: Neurology Authors: Beck, C. A., Beran, D. B., Biglan, K. M., Boyd, C. M., Dorsey, E. R., Schmidt, P. N., Simone, R., Willis, A. W., Galifianakis, N. B., Katz, M., Tanner, C. M., Dodenhoff, K., Aldred, J., Carter, J., Fraser, A., Jimenez-Shahed, J., Hunter, C., Spindler, M., Tags: Parkinson's disease/Parkinsonism, Clinical trials Randomized controlled (CONSORT agreement) ARTICLE Source Type: research